Session Information
Date: Tuesday, September 24, 2019
Session Title: Dystonia
Session Time: 1:45pm-3:15pm
Location: Les Muses Terrace, Level 3
Objective: We had proposed to evaluate appearance of anxiety and depression in patients with cervical dystonia(CD) and influence of disease on the quality of life.
Background: CD is characterized by involuntary muscle of the neck and head. Botulinum toxin injections are the treatment of choice.
Method: CD severity was measured with the Toronto Western Spasmodic Torticollis Rating Scale(TWSTRS). Psychiatric symptoms were evaluated with Beck Depression Inventory and Beck Anxiety Inventory. Follow-up period was 1.5 years.
Results: A total of 29 patients were analyzed. Our subjects had mild CD. Depression was observed in 19 patients(65.5%) and anxiety in 10 patients(34.5%). Disability affects multiple aspects including pain, social life, physical function, daily activity.
Conclusion: Our take home message is that CD disability could lead to depression and anxiety. Fortunately, these are potentially treatable conditions, highlighting the importance of recognizing those and initiating proper treatment.
To cite this abstract in AMA style:
M. Munteanu. Depression and anxiety in cervical dystonia [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/depression-and-anxiety-in-cervical-dystonia/. Accessed October 25, 2026.« Back to 2019 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/depression-and-anxiety-in-cervical-dystonia/